BamSEC and AlphaSense Join Forces
Learn More

Immunovant Inc.

NASDAQ: IMVT    
Share price (12/20/24): $25.86    
Market cap (12/20/24): $3.796 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 10 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 10 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 10 pages Share Purchase Agreement Article 1 Definitions
12/34/56
EX-10.24
from 10-K 11 pages Employment Agreement
12/34/56
EX-10.6
from 10-Q 8 pages Immunovant, Inc. Restricted Stock Unit Grant Notice
12/34/56
EX-10.5
from 10-Q 8 pages Immunovant, Inc. Stock Option Grant Notice
12/34/56
EX-10.4
from 10-Q 25 pages Immunovant, Inc. 2023 Inducement Plan Adopted by the Board of Directors: February 1, 2023
12/34/56
EX-10.3
from 10-Q 13 pages Immunovant, Inc. Restricted Stock Unit Grant Notice – NON-U.S
12/34/56
EX-10.2
from 10-Q 12 pages Immunovant, Inc. Stock Option Grant Notice – NON-U.S
12/34/56
EX-10.1
from 10-Q 2 pages Uk Sub-Plan to the Immunovant, Inc. 2019 Equity Incentive Plan
12/34/56
EX-10.16
from 10-K 23 pages Employment Agreement
12/34/56
EX-10.3
from 10-Q 12 pages Samsung Biologics Co., Ltd. Product Service Agreement — Commercial Product Drug Substance
12/34/56
EX-10.2
from 10-Q 31 pages Master Services Agreement Between Samsung Biologics Co., Ltd. and Immunovant Sciences Gmbh
12/34/56
EX-10.1
from 10-Q 24 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 24 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 10 pages Share Purchase Agreement
12/34/56
EX-10.1
from 8-K 3 pages Consulting Agreement
12/34/56
EX-10.17
from 10-K 22 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 11 pages (Revised November 5, 2020) Brad Middlekauff [***] Re: Separation Agreement and General Release Dear Brad,
12/34/56
EX-10.17
from S-1 22 pages Employment Agreement
12/34/56